The proliferation of drug ads from telehealth companies on social-media platforms puts children and patients at risk, Sens. Dick Durbin (D-Ill) and Mike Braun (R-Ind) wrote in a letter to the FDA commissioner.

Respiratory disease declined 27% but were offset by a large rise in chronic respiratory conditions.

Under the new proposal, which was expanded to include more borrowers, eligibility must meet certain criteria, such as those who have been in repayment for a long time or those whose loans exceed what they originally owed.

Offering group health coverage is important to small businesses. More than 9 in 10 said it's important, with 69% calling it "extremely important."

9 in 10 employers are concerned about high-cost drugs in the pipeline, with a similar number reporting concern about pharmacy cost trends overall.

The agency is exploring if the companies that broker drug purchases for hospitals, along with the drug distributors, are pushing the prices of generics so low that they've made it hard for manufacturers to maintain production.

The Centers for Medicare & Medicaid Services made "historic strides" in making health care and prescription drugs affordable, said Administrator Chiquita Brooks-LaSure, who updated stakeholders about CMS's accomplishments.

PhRMA argued that the Inflation Reduction Act delegated too much power to HHS, however, the DOJ said the industry association lacked standing because it doesn't manufacture or sell prescription drugs.